Eye Disorders I Flashcards

1
Q

Functions of the lens

A

• The lens can adapt and change shape (accommodation) in order to change the direction of a light wave (refraction).
This allows us to focus on an image.
• As we get older (usually starting in our 40s), our ability to have our lens change shape weakens.
• This causes us to need reading glasses as we can’t focus on close objects.
• We completely lose this ability when we are about 55-60.
• Then lens also blocks harmful ultraviolet (UV) light from entering the eye

attached to zonules which attach to ciliary bodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Dry Eye Disease

A

•Dry eye disease is an multifactorial, inflammatory
disease involving the entire lacrimal
functioning unit.
inflamm involved, dk if it causes it or is caused by dry eye
• Management of the condition mostly focuses on
replenishing the deficient tear layer.
• May not necessarily treat the cause of the inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Components of tears:

A
  • Lipid: Slows down evaporation of tears secreted by Meibomian glands
  • Aqueous: Supplies moisture; aka watery component, secreted by lacrimal gland
  • Mucin: Coats the eye to allow the aqueous layer to stick to a water repellent cornea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pathophysiology:
Aqueous-Deficient Dry Eye
Refers to not producing enough aqueous or mucin.

A
  • Type 1: Sjogren syndrome
  • Autoimmune disease that involves damage to goblet cells that are involved in tear production (mucin).
  • Type 2: Non-Sjogren syndrome
  • Primary or Secondary lacrimal gland deficiencies
  • Obstruction of lacrimal ducts
  • Reflex hyposecretion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pathophysiology:
Evaporative Dry Eye (EDE)
• Characterized by a high level of tear evaporation

A
  • External
  • Environmental Factors
  • High temperature or low humidity
  • Certain exposures to sun, dust and wind.

• Internal
• Meibomian gland dysfunction
• Chronic inflammation that leads to squamous debris, gland obstruction and
changes in glandular section.

  • Intrinsic
  • Conditions that affect closing of eyelids or decreased blinking.

• Other Risk Factors
• Thyroid dysfunction, laser eye surgery, medications (oral contraceptives), excessive
digital/screen time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Aqueous or Evaporative Dry Eye: Symptoms

Aqueous and Evaporative dry eye are not separate entities and they
are believed to exist on a continuum.

  • The tricky thing is patients may have:
  • Symptoms but no physical signs on the eye
  • Signs on the eye but no symptoms
A
  • Stinging/ gritty/ scratchy eyes
  • Fluctuating vision (intermittent blur)
  • Burning or feeling of a foreign body in the eye
  • Severe cases: Blurry vision, light sensitivity, excess tear production.
  • Over time can lead to inflammation/redness around the eyes
  • History/Onset:
  • Can develop over days, months or years.
  • Sometimes patients get used to the symptoms so symptoms “go away
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Management: Non-Pharmacologic

A
  1. Education on environmental management
    • Using a humidifier or adjusting temperature at home. (winter time due to hea)
    • Blinking exercises
  2. Reassessing systemic medications
  3. Warm Compress
    • Using a warm cloth, place over eyelids for 5-10 minutes.
    • Patient must keep rewetting cloth; a better solution is a Bruder Mask that stays hot for 10 minutes.
    (need to be warmed longer for movement in eyes)
  4. Other: lipiflow, radiofrequency, intense pulse light
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Management: Pharmacologic

A

Artificial Tears
• So many on the market, preferences based on clinician and samples available.
• Preservative containing versus Preservative free.
• Look at the four categories to determine equivalencies between drops.
• Cost
• Viscosity
• Demulcents
• Emollients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Preservative Containing Drops

A

• The preservative prevents bacterial growth.
• Most common and the cheapest.
mutidose vials, exposed to environment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Preservative Free Minums

A

• They are usually in vials called minums.
•Can be expensive ($$$)
•Generally recommended if patient requires
frequent drop use (ie. After eye surgery) (more than 4x.day)

one use only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Management: Pharmacologic

A

• Cost (more important)

  • Viscosity agent (more important)
  • Determines length of action
  • Lower viscosity (Short acting, eye drops)
  • Higher viscosity (Long acting, gels and ointments)
  • Demulcents (less important)
  • Protect and lubricates mucous membranes, relieves dryness.
  • Emollients (less important)
  • Protect and soften tissues, prevents drying and cracking
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Artificial Tears

A
  • Viscosity
  • Lower: Eye drops
  • Good for all day use.
  • Does not disrupt vision after use.
  • Needs to be used at an increased frequency.

• Higher: Gels and Ointments
• Better for use at night time or before bed.
• Blurry vision after use.
• Longer lasting type of tear
don’t use with contact lens, smears on lens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Systane Ultra vs Systane Balance vs Systane complete

A

key diff:

ultra: just aqeious layer (demulcent)
balance: has a lipid component too

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Commonly Recommended Gels and

Ointments

A
• Liposic
• Lacrilube
• Systane gel ointment
• Refresh PM
give to pt who sleep with eyes open to shield cornea from drying out
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Management: Prescription Medications

• Topical (Ophthalmic) corticosteroids:

A
  • Examples:
  • Lotemax/Alrex (Loteprednol 0.5%)
  • FML (Fluorometholone 0.1%)

• Mechanism of Action:
• Anti-inflammatory corticosteroid. Inhibits inflammatory processes
and mediators of inflammation.
• *Dose and length of therapy is dependent on the diagnosis and
steroid chosen–> commonly tapered but not always

  • Adverse Effects: Blurred vision, photophobia, burning/stinging
  • Length of Therapy: 14 – 28 days
  • Onset of Effect: Generally would expect benefit within a week

NSAIDS do not work for DED, rsiks of integrity of cornea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Management: Prescription Medications

• Restasis (Cyclosporine 1% ophthalmic solution)

A

• Mechanism of Action:
• Exact action unclear
• Increases goblet cell density -> increase mucin, allows tear film to bind
• Thought that it is a partial immunomodulator in patients whose tear production is
suppressed due to ocular inflammation.

  • Ophthalmic Dose: 1 drop into each eye twice daily
  • Adverse Effects: Burning eyes
  • Length of Therapy: Lifelong
  • Onset of Effect: Expect benefit in 12 weeks (90 days to get better, give steroid concurrently to bridge)

some ppl use twice before throwing

17
Q

Management: Prescription Medications

• Xiidra (lifitegrast 5% ophthalmic solution)

A
  • Mechanism of Action:
  • Exact mechanism is unknown
  • Blocks key inflammatory markers
  • Ophthalmic Dose: 1 drop into each eye twice daily
  • Adverse Effects: Dysgeusia (altered taste), blurred vision, irritation/burning eyes
  • Length of Therapy: Lifelong
  • Onset of Effect: Some patients may experience improvement in symptoms as early as 2 weeks but can be up to 12 weeks.
18
Q

Conjunctivitis

Allergic, Bacterial and Viral

A

• Refers to inflammation to the conjunctiva.
• Can be caused by allergies, viral and/or bacterial infections
wraps around scleara and eyelid
skin thats red not eyeball

• Hypersensitivity reaction to allergens
• Seasonal
• Allergens such as pollen from trees, grass, weeds and flowers.
• Timing usually is in spring/summer/fall, depends what allergen the patient is
sensitive to.
• Perennial
• Allergen from dust, pets (eg. Dander from cats)
• Can happen all year round.

19
Q

Symptoms of conjuctivitis

A
  • Usually itchy, irritated and red eyes
  • Often accompanied with nasal congestion or sneezing.
  • Sometimes swollen eyelid
  • Never ocular pain or light sensitivity.
  • Generally you will see BOTH eyes affected.
20
Q

Management: Non-Pharmacologic

A
• Avoid allergens
• Cold compresses
• Avoid rubbing of the eyes
• Minimize contact lens wear
• Artificial Tears
• Rationale: Helps moves/flush allergens out of the eye and reduces the
inflammatory response.
21
Q

Management: Pharmacologic
• Antihistamine/Decongestant
• Example: Pheniramine/naphazoline (Naphcon A

low systemic ffect, might be ok for HTN
plug lacrimal duct to lower syst abs

A

Mechanism of Action:
• Block histamine receptors and provides faster relief than oral
antihistamines.
• Constrict blood vessels to reduce redness.
• Ophthalmic Dose: 1-2 drops up to 4 times per day (freq use)
• Adverse Effects: Can cause eye irritation or burning, contraindicated in patients with angle-closure glaucoma, if used for extended time can cause rebound redness.
• Length of Therapy: Used as needed
• Onset of Action: Symptoms will start to improve within the day

rebound effect after use for a long time

22
Q

Management: Pharmacologic
• Mast cell stabilizers
• Example: Cromolyn

A

• Mechanism of Action:
• Prevents the mast cells from releasing contents that leads to a inflammation
response.
• Ophthalmic Dose: 1-2 drops up to 4 times per day
• Adverse Effects: Can cause eye or burning.
• Length of Therapy: Used as needed
• Onset of Action: 3-5 days before any relief

23
Q

Management: Pharmacologic
• Combination Mast Cell Stabilizer/Antihistamine
• Example: Olopatadine (Patanol 1%, Pataday 2%, Pazeo 7%)
• Example: Bepotasine (Bepreve) 1.5%

more common

A

• Mechanism of Action:
• Block histamine receptors and stabilizes mast cells.
• Ophthalmic Dose: 1 drops once (Pataday, Pazeo) or twice a day
(Patanol, Bepreve)
• Adverse Effects: Can cause eye irritation if used too long
• Length of Therapy: Used as needed
• Onset of Action: Symptoms will start to improve within the day

24
Q

What is the most common organism that
causes red eyes (conjunctivitis)?

  • A) Bacteria
  • B) Virus
  • C) Fungus
  • D) Anerobes
A

B viral

  • Bacterial:
  • Direct contact with contaminated surfaces causing an alteration in bacterial flora on the ocular surface.
  • Viral:
  • Most commonly caused by adenoviruses spread by respiratory droplets, or coming in contact with the eyes by fingers.
  • COVID-19: This virus can also cause viral conjunctivitis!
25
Q

Risk Factors of conjunc

A

• Certain occupations ( ie: Patient working in the hospital, working at a
day care, works with children, etc)
• Contact lens wearers
• History of Herpes (simplex or zoster)

26
Q

Symptoms/Presentation: Bacterial Infections of conj

A

• Ocular redness (one or both eyes)
• Usually not itchy, just uncomfortable.
• No history of a cold/ sinus problems
• Yellow discharge with crusts in the morning, sticky eyelids
• Papillae/ follicles on lid inversion.
papillae not folliciles for bacterial inf
no central vessel

27
Q

Symptoms/Presentation:

Viral Infections of conj

A
• Eye redness (one or both eyes)
• Usually not itchy
• Patient is getting over a cold/ has a cold
• Watery eyes
• Papillae/follicles upon lid inversion.
clear, no discharge
28
Q

Which of the following infections will self
resolve on its own?
• A) Bacterial conjunctivitis
• B) Viral Conjunctivitis
• C) Both; bacterial and viral
• D) Neither; both require antibacterials or antivirals

A

• C) Both; bacterial and viral

29
Q

Management of Bacterial Conjunctivitis:
Pharmacologic
• Topical (Ophthalmic) Antibiotics
speed up recovery

A
  • Polymyxin B (Polysporin)
  • Tobramycin
  • Moxifloxacin (Vigamox)

• Dose: Dependent on the antibiotic, generally used 3-4x/day
• Adverse Effects: Based on agent used, but range from well tolerated to blurry vision/irritation
• Length of Therapy: 7 – 10 days
• Length of Disease w/o Therapy: 14 days
contagious until 24 hours of taking abx

30
Q

Management of Bacterial Conjunctivitis:
Pharmacologic
• Fusidic Acid 1% (Fucithalmic) Eye drops

A

• Commonly prescribed by family physicians.
• Not a great antibiotic to use for bacterial conjunctivitis
• Organisms develop resistance readily.
• Therefore educate patient to see optometrist if conjunctivitis does not improve in the next 1-2 days.
could adapt?

31
Q

Management of Viral Conjunctivitis:

Pharmacologic

A
  1. Cool compresses & Artificial Tears
  2. Corticosteroids (For symptomatic relief) - increase viral replication, feels better
  3. Length of Disease with or without therapy: 14 –
    21 days
    • Severe Cases: Betadine (povidone-iodine) wash in
    office.
32
Q

Keratitis

A

• Refers to inflammation to the cornea most commonly due to
bacterial or viral causes.

• Pathophysiology and Risk Factors
• Similar as bacterial/viral conjunctivitis except inflammation involves the cornea.
• Key: Refer if your patient is sensitive to light; if the eye is painful; or there
is a foreign body sensation.

33
Q

Keratitis

Management: Pharmacologic

A

Bacterial Keratitis:
• Topical (Ophthalmic) Antibiotics
• Fluoroquinolone eye drops Q1H
• Examples: besifloxacin, moxifloxacin, gatifloxacin
• Viral Keratitis (specially: Herpes Simplex & Zoster):
• If HSV: Topical Trifluridine 1% (Viroptic) 8x/day
• Can see topical corticosteroids or oral antivirals as well.
• In some situations, topical corticosteroids should not be used